A PIVOT towards single-cell functional genetic screening in plants

Nature Biotechnology, Published online: 05 May 2026; doi:10.1038/s41587-026-03141-0

We developed PIVOT, a single-cell screening platform for functional characterization of plant genes. PIVOT enables delivery of gene libraries to tobacco leaves with single multiplicity of infection and magnetic sorting of single plant cells by phenotype. We use PIVOT to recover regulators of cytokinin signaling from an Arabidopsis open reading frame library.

Autonomous pathology research using agentic AI shows potential in oncology

Nature Medicine, Published online: 05 May 2026; doi:10.1038/s41591-026-04403-9

The agentic artificial intelligence tool SPARK is able to reproduce pathology-based reasoning and produce biological hypotheses and relevant diagnostic, prognostic and predictive cellular parameters. The output of SPARK has the potential to advance the understanding of tumor biology and enable the development of diagnostic, prognostic and predictive tools for pathology and oncology.

Anxiety and Depression Associated With the Dependent Use of Generative AI in Medical Students: Cross-Sectional Study

Background: The growing integration of artificial intelligence (AI) in higher education has transformed learning processes but also raised concerns about potential mental health risks. Medical students represent a particularly vulnerable group due to high academic stress and increasing reliance on generative AI tools for study and decision-making tasks. Despite this, the relationship between AI dependence and psychological distress remains underexplored in Latin American contexts. Objective: This study aimed to evaluate the association between generative AI dependence and levels of stress, anxiety, and depression among medical students. Methods: A cross-sectional study was conducted with 187 human medicine students from a Peruvian university during the first academic semester of 2025. The Dependence on Artificial Intelligence Scale and the Depression, Anxiety, and Stress Scale–21 were applied. Negative binomial regression models, both crude and adjusted for sex, age, income, and year of study, were used to assess associations, reporting rate ratios (RRs) and 95% CIs. Results: Participants had a median age of 22 (IQR 19‐24) years, and 58.8% (110/187) were female. The median Dependence on Artificial Intelligence Scale score was 10 (IQR 7‐14). Generative AI dependence showed significant correlations with anxiety (ρ=0.336, 95% CI 0.22‐0.44) and depression (ρ=0.316, 95% CI 0.20‐0.43) and a smaller correlation with stress (ρ=0.277, 95% CI 0.16‐0.39). In the adjusted regression models, each 1-point increase in generative AI dependence was associated with a 5% higher expected anxiety score (RR 1.05, 95% CI 1.01‐1.09; =.01) and a 4% higher depression score (RR 1.04, 95% CI 1.01‐1.08; =.03), whereas the association with stress was positive but nonsignificant (RR 1.03, 95% CI 1.00‐1.07; =.08). Fifth-year students had significantly greater anxiety levels than their sixth-year peers (RR 1.82, 95% CI 1.09‐3.01; =.02). No significant effects were observed for sex, age, or income. Conclusions: This study empirically examined generative AI dependence as a distinct behavioral construct and its association with mental health symptoms in medical students. Unlike prior research, this study evaluated psychological dependence on generative AI and modeled its relationship with anxiety and depression using appropriate count-based regression techniques. By providing early evidence from a Latin American context, it contributes to the emerging field of digital mental health and medical education research. These findings underscore the need for universities to promote balanced and responsible AI use, integrate digital literacy with mental health support strategies, and develop preventive policies that mitigate potential maladaptive reliance on generative AI tools.
<img src="https://jmir-production.s3.us-east-2.amazonaws.com/thumbs/63c5cab6261231002a3eb9a11707995f" />

STAT+: Did AI really beat doctors at diagnosis?

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.

Good morning health tech readers!

In two weeks, we’re holding our Breakthrough Summit West in San Francisco. I’ll be there interviewing OpenEvidence co-founder and CTO Zachary Ziegler. The agenda is positively loaded, and there’s still time to register.

Continue to STAT+ to read the full story…